2012

December 11 2012
BTG plc: US FDA approves expanded ZYTIGA® indication for treatment of metastatic castration-resistant prostate cancer

London, UK, 11 December 2012 BTG plc (LSE: BTG), the specialist healthcare company, notes the announcement by Janssen that the US Food and Drug Administration (FDA) has approved the use of...

Show 5102550100 per page
Top